
Lewis L. Lanier, PhD
American Cancer Society Research Professor; and Chair, Department of Microbiology and Immunology, UCSF
Leader, Cancer, Immunity, and Microenvironment Program, UCSF Helen Diller Family Comprehensive Cancer Center
Member, UCSF Biomedical Sciences Graduate Program (BMS)
Member, UCSF Herbert W. Boyer Program in Biological Sciences (PIBS)
Member, UCSF Immunology Graduate Program
Contact
.(JavaScript must be enabled to view this email address)
(415) 514-0829 (voice)
(415) 502-8424 (fax) (fax)
Box 0414, UCSF; San Francisco, CA 94143-0414
Additional websites:
Lanier Lab Website
Education
Virginia Polytechnic Institute & State U., Blacksburg, VA, B.S. (honors), 1975, Microbiology
Univ. North Carolina - Chapel Hill, NC, Ph.D., 1978, Immunology
Univ. North Carolina - Chapel Hill, NC, Postdoc, 1978-79, Immunology
Univ. New Mexico Med Sch, Albuquerque, NM, Postdoc, 1979-81, Immunology
Professional Experience
- 1981-1988
Senior Research Scientist, Becton Dickinson Monoclonal Center, Inc.
- 1988-1990
Associate Research Director, Becton Dickinson Immunocytometry Systems
- 1991-1992
Senior Scientific Staff, Department of Immunology, DNAX Research Institute
- 1993-1996
Associate Director, Department of Human Immunology, DNAX Research Institute
- 1997-1999
Director, Department of Immunobiology, DNAX Research Institute
- 1999-present
Professor, Department of Microbiology & Immunology and Cancer Research Institute, University of California, San Francisco
- 2003-2010
Vice Chair, Department of Microbiology & Immunology, University of California, San Francisco
- 2010
Chair, Department of Microbiology & Immunology, University of California, San Francisco
Honors & Awards
- 1971
Virginia Polytechnic Institute and State University Freshman Science Scholarship
- 1978-1979
National Research Service Award Fellowship, University of North Carolina School of Medicine at Chapel Hill Cancer Research Center
- 1979-1981
Damon Runyon - Walter Winchell Cancer Fund Postdoctoral Fellowship
- 2001
American Association of Immunologists Distinguished Service Award
- 2002
William B Coley Award for Distinguished Research in Basic and Tumor Immunology, Cancer Research Institute, New York
- 2003
American Cancer Society Research Professorship
- 2005
American Society for Histocompatibility and Immunogenetics Rose Payne Award
- 2006
NIH Merit Grant Award
- 2010
Member, National Academy of Sciences
Selected Publications
-
Lanier, L.L., M. Lynes, G. Haughton and P.J. Wettstein. 1978. Novel type of murine B cell lymphoma. Nature 271:554. PMID: 99664. PMCID: N/A
-
Allison, J.P. and L.L. Lanier. 1985. Identification of antigen receptor-associated structures on murine T cells. Nature 314:107. PMID: 2579338. PMCID: N/A
-
Lanier, L.L. and A. Weiss. 1986. Presence of Ti (WT31) negative T lymphocytes in normal blood and thymus. Nature 324:268. PMID: 3491323. PMCID: N/A
-
Lanier, L.L., S. Cwirla, G. Yu, R. Testi and J.H. Phillips. 1989. Membrane anchoring of a human IgG Fc receptor (CD16) determined by a single amino acid. Science 246:1611-1613. PMID: 2531919. PMCID: N/A
-
Lanier, L.L., G. Yu and J.H. Phillips. 1989. Co-association of CD3z with receptor (CD16) for IgG on human natural killer cells. Nature 342:803. PMID: 2532305. PMCID: N/A
-
Azuma, M., D. Ito, H. Yagita, K. Okumura, J.H. Phillips, L.L. Lanier and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76. PMID: 7694153. PMCID: N/A
-
Phillips, J.H., J. Gumperz, P. Parham and L.L. Lanier. 1995. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268:403-405. PMID: 7716542. PMCID: N/A
-
Lanier, L.L., B.C. Corliss, J. Wu, C. Leong and J.H. Phillips. 1998. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391:703. PMID: 9490415. PMCID: N/A
-
Braud, V.M., D.S.J. Allan, C.A. O'Callaghan, K. Soderstrom, A. D'Andrea, G.S. Ogg, S. Lazetic, N.T. Young, J.I. Bell, J.H. Phillips, L.L. Lanier and A.J. McMichael. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B, and C. Nature 391:795-799. PMID: 9486650. PMCID: N/A
-
Bauer, S., V. Groh, J. Wu, A. Steinle, J.H. Phillips, L.L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727-729. PMID: 10426993. PMCID: N/A
-
Wu, J., Y. Song, A.B.H. Bakker, S. Bauer, T. Spies, L.L. Lanier, and J.H. Phillips. 1999. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285:730. PMID: 10426994. PMCID: N/A
-
Paloneva, J., M. Kestila, J. Wu, A. Salminen, T. Bohling, V. Ruotsalainen, P. Hakola, A.B.H. Bakker, J.H. Phillips, P. Pekkarinen, L.L. Lanier, T. Timonen, and L. Peltonen. 2000. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nature Genetics 25:357-361. PMID: 10888890. PMCID: N/A
-
Lanier, L.L. 2001. On guard - activating NK cell receptors. Nature Immunology 2:23-27. PMID: 11135574
-
Cerwenka, A., A.B.H. Bakker, T. McClanahan, J. Wagner, J. Wu, J.H. Phillips, and L.L. Lanier. 2000. Retinoic acid-early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12:721. PMID: 10894171. PMCID: N/A
-
Bakker, A.B.H., R.M. Hoek, A. Cerwenka, B. Blom, L. Lucian, T. McNeil, R. Murray, J.H. Phillips, J.D. Sedgwick, and L.L. Lanier. 2000. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13:345. PMID: 11021532. PMCID: N/A
-
Ravetch, J.V. and L.L. Lanier. 2000. Immune inhibitory receptors. Science 290:84-89. PMID: 11021804. PMCID: N/A
-
Wu, J., H. Cherwinski, T. Spies, J.H. Phillips, and L.L. Lanier. 2000. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J. Exp. Med. 192:1059-1067. PMID: 11015446. PMCID: PMC2193316
-
Cerwenka A, Baron JL, and Lanier LL. 2001. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits NK cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 98:11521. PMID: 11562472. PMCID: PMC58762
-
Arase, H., T. Saito, J.H. Phillips, and L.L. Lanier. 2001. Cutting Edge: The mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (a2 integrin, very late antigen-2). J. Immunol. 167:1141-1144. PMID: 11466327. PMCID: N/A
-
Arase, H., E.S. Mocarski, A.E. Campbell, A.B. Hill, and L.L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296:1323. PMID: 11950999. PMCID: N/A
-
Lodoen, M., K. Ogasawara, J.A. Hamerman, H. Arase, J.P. Houchins, E.S. Mocarski, and L.L. Lanier. 2003. NKG2D-mediated NK cell protection against cytomegalovirus is impaired by gp40 modulation of RAE-1 molecules. J. Exp. Med. 197:1245. PMID: 12756263. PMCID: PMC2193789
-
Ogasawara, K. J.A. Hamerman, H. Hsin, S. Chikuma, H. Jordon, T. Chen, T. Pertel, C. Carnaud, J.A. Bluestone and L.L. Lanier. 2003. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18:41. PMID: 12530974. PMCID: N/A
-
Zompi, S., J.A. Hamerman, K. Ogasawara, E. Schweighoffer, V.L.J. Tybulewicz, J.P. DiSanto, L.L. Lanier, and F. Colucci. 2003. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nature Immunology 4:565-572. PMID: 12740576. PMCID: N/A
-
Rosen, D.B. M. Araki, J.A. Hamerman, T. Chen, T. Yamamura, and L.L. Lanier. 2004. A structural basis for the association of DAP12 with mouse, but not human, NKG2D. J. Immunol. 173:2470-2478. PMID: 15294961. PMCID: N/A
-
Lodoen, M., G. Abenes, S. Umamoto, J.P. Houchins, F. Liu, and L.L. Lanier. 2004. The cytomegalovirus m155 gene product subverts NK cell antiviral protection by disruption of H60-NKG2D interactions. J. Exp. Med. 200:1075. PMID: 15477345. PMCID: PMC2211837
-
Hamerman, J.A., K. Ogasawara, and L.L. Lanier. 2004. Cutting Edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J. Immunol. 172:2001-2005. PMID: 14764662. PMCID: N/A
-
Lanier, L.L. 2005. NK cell recognition. Annu. Rev. Immunol, 23:225. PMID: 15771571
-
Takaki, R., Y. Hayakawa, A. Nelson, P.V. Sivakumar, S. Hughes, M.J. Smyth, and L.L. Lanier. 2005. IL-21 enhances tumor rejection through a NKG2D-dependent mechanism. J. Immunol. 175:2167-2173. PMID: 16081783. PMCID: N/A
-
Hamerman, J.A., N. K. Tchao, C.A. Lowell, and L.L. Lanier. 2005. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nature Immunology 6:579. PMID: 15895090. PMCID: PMC1282462
-
Ogasawara, K., J. Benjamin, R. Takaki, J.H. Phillips, and L.L. Lanier. 2005. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nature Immunology 6:938. PMID: 16086018. PMCID: PMC1351289
-
Routes, J.M., S. Ryan, K. Morris, R. Takaki, A. Cerwenka, and L.L. Lanier. 2005. Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection. J. Exp. Med. 202:1477. PMID: 16314433. PMCID: PMC2213342
-
Rosen, D.B., J. Bettadapura, M. Alsharifi, P.A. Mathew, H.S. Warren, and L.L. Lanier. 2005. Cutting Edge: Lectin-like transcript-1 (LLT1) is a ligand for the inhibitory human NKR-P1A receptor. J. Immunol. 175:7796. PMID: 16339513. PMCID: N/A
-
Chen, S., H. Kawashima, J.B. Lowe, L.L. Lanier, and M. Fukuda. 2005. Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment. J. Exp. Med. 202:1679-1689. PMID: 16352740. PMCID: PMC2212958
-
Shiow, L.R., D.B. Rosen, N. Brdickova, Y. Xu, J. An, L.L. Lanier, J.G. Cyster, and M. Matloubian. 2006. CD69 acts downstream of interferon-a/b to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440:540-544. PMID: 16525420. PMCID: N/A
-
Hesslein, D.G.T., R. Takaki, M.L. Hermiston, A. Weiss, and L.L. Lanier. 2006. Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production. Proc. Natl. Acad. Sci. USA 103:7012. PMID: 16627620. PMCID: PMC1459010
-
Hamerman, J.A., J.R. Jarjoura, M.B. Humphrey, M.C. Nakamura, W.E. Seaman, and L.L. Lanier. 2006. Cutting Edge: Inhibition of Toll-like receptor and Fc-receptor responses in macrophages by TREM-2 and DAP12. J. Immunol. 174:2051. PMID: 16887962. PMCID: N/A
-
Carr, W.H., D.B. Rosen, H. Arase, D.F. Nixon, J. Michaelsson, and L.L. Lanier. 2007. Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J. Immunol. 178:647. PMID: 17202323. PMCID: PMC2561215
-
Kim, J., C.K. Chang, T. Hayden, F-C. Liu, J. Benjamin, J.A. Hamerman, L.L. Lanier, and S-M. Kang. 2007. The activating immunoreceptor NKG2D and its ligands are involved in allograft transplantation rejection. J. Immunol. 179:6416. PMID: 17982029. PMCID: 17982029
-
Vilarinho, S., K. Ogasawara, S. Nishimura, L.L. Lanier, and J.L. Baron. 2007. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc. Natl. Acad. Sci. U.S.A. 104:18187. PMID: 17991774. PMCID: PMC2084318
-
Fang, M., L.L. Lanier, and L. Sigal. 2008. A role for NKG2D in NK cell-mediated resistance to poxvirus disease. Plos Pathogen 4,e30. PMID: 18266471. PMCID: PMC2233669
-
Satoh, T., J. Arii, T. Suenaga, J. Wang, A. Kogure, J. Uehori, N. Arase, I. Shiratori, S. Tanaka, Y. Kawaguchi, P.G. Spear, L.L. Lanier, and H. Arase. 2008. PILRa is a herpes simplex-virus-1 entry co-receptor that associates with glycoprotein B. Cell 132:935. PMID: 18358807. PMCID: PMC2394663
-
Sun, J.C. and L.L. Lanier. 2008. Tolerance of NK cells encountering their viral ligand during development. J. Exp. Med. 205:1819. PMID: 18606858. PMCID: PMC2525590
-
Lanier, L.L. 2008. Up on the tightrope: Natural Killer cell activation and inhibition. Nature Immunology 9:495. PMID: 18425106. PMCID: PMC2669298
-
Sun, J.C. and L.L. Lanier. 2008. Cutting Edge: Viral Infection Breaks NK Cell Tolerance to "Missing Self". J. Immunol. 181:7453. PMID: 19017932. PMCID: PMC2587071
-
Sun, J.C., J.N. Beilke, and L.L. Lanier. 2009. Adaptive immune features of Natural Killer cells. Nature 457:557. PMID: 19136945. PMCID: PMC2674434
-
Kielczewska, A., M. Pyzik, T. Sun, A. Krmpotic, M.B. Lodoen, M. Munks, M. Babic, A.B. Hill, U.H. Koszinowski, S. Jonjic, L.L. Lanier, and S.M. Vidal. 2009. Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 is associated with NK cell-mediated resistance to infection. J. Exp. Med. 206:515. PMID: 19255146. PMCID: PMC2699136
-
Orr, M.T., J.C. Sun, D.G.T Hesslein, H. Arase, J.H. Phillips, T. Takai, and L.L. Lanier. 2009. Ly49H signaling through both DAP10 and DAP12 is required for optimal NK cell responses to mouse cytomegalovirus infection. J. Exp. Med. 206:807. PMID: 19332875. PMCID: PMC2715124
-
Sun, J.C., A. Ma, and L.L. Lanier. 2009. Cutting Edge: IL-15-independent NK cell response to mouse cytomegalovirus infection. J. Immunol. 183:2911. PMID: 19648279. PMCID: PMC2745285
-
Cao, W., L. Bover, M. Cho, X. Wen, S. Hanabuchi, M. Bao, D.B. Rosen, Y-H. Wang, J.L. Shaw, Q. Du, C. Li, N. Arai, Z. Yao, L.L. Lanier, and Y-J. Liu. 2009. Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J. Exp. Med. 206:1603. PMID: 19564354. PMCID: PMC2715090
-
Orr, M.T., W.J. Murphy, and L.L. Lanier 2010. "Unlicensed" NK cells dominate the response to cytomegalovirus infection. Nature Immunology, 11:321.
Updated: January 20, 2012